Clinical Trial Update: A Study of Chlorhexidine in the Prevention of HIV-1 Transmission From Mothers to Their Babies [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated chlorhexidine for the prevention of mother-to-child transmission of HIV-1. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Chlorhexidine (chlorhexidine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED